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Ebola virus infection of human dendritic cells (DCs) induces atypical adaptive immune
responses and thereby exacerbates Ebola virus disease (EVD). Human DCs, infected
with Ebola virus aberrantly express low levels of the DC activation markers CD80, CD86,
and MHC class II. The T cell responses ensuing are commonly anergic rather than
protective against EVD. We hypothesize that DCs derived from potential reservoir hosts
such as bats, which do not develop disease signs in response to Ebola virus infection,
would exhibit features associated with activation. In this study, we have examined Zaire
ebolavirus (EBOV) infection of DCs derived from the Angolan free-tailed bat species,
Mops condylurus. This species was previously identified as permissive to EBOV infection
in vivo, in the absence of disease signs.M. condylurus has also been recently implicated
as the reservoir host for Bombali ebolavirus, a virus species that is closely related to
EBOV. Due to the absence of pre-existing M. condylurus species-specific reagents,
we characterized its de novo assembled transcriptome and defined its phylogenetic
similarity to other mammals, which enabled the identification of cross-reactive reagents
for M. condylurus bone marrow-derived DC (bat-BMDC) differentiation and immune cell
phenotyping. Our results reveal that bat-BMDCs are susceptible to EBOV infection as
determined by detection of EBOV specific viral RNA (vRNA). vRNA increased significantly
72 h after EBOV-infection and was detected in both cells and in culture supernatants.
Bat-BMDC infection was further confirmed by the observation of GFP expression in
DC cultures infected with a recombinant GFP-EBOV. Bat-BMDCs upregulated CD80
and chemokine ligand 3 (CCL3) transcripts in response to EBOV infection, which
positively correlated with the expression levels of EBOV vRNA. In contrast to the aberrant
responses to EBOV infection that are typical for human-DC, our findings from bat-BMDCs
provide evidence for an immunological basis of asymptomatic EBOV infection outcomes.
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INTRODUCTION
Ebola virus [(EBOV) species Zaire ebolavirus, Filoviridae], has
jumped the species barrier resulting in more than 15 separate
human outbreaks since its discovery in the Democratic Republic
of Congo (DRC), formerly Zaire, in 1976 (1). Ebola virus
disease (EVD) in humans is characterized by a sudden onset of
fever, malaise, chills, headache, myalgia, which can progress to
severe gastrointestinal, respiratory, and neurological symptoms,
haemorrhagic fever, meningoencephalitis, pancreatitis, hepatic
and renal injury [reviewed in (2, 3)]. Fatality rates are strain-
dependent and range between 40 and 90% with many patients
succumbing to internal hemorrhaging or multiple organ failure
(1) partially as a result of aberrant cytokine and chemokine
production (4) and impaired adaptive immune responses (5).
Significant inroads into controlling EBOV outbreaks have
been made, including the development and implementation of
ring vaccination methodologies [reviewed in (6)]. Despite this, in
areas where public health responses are hindered such as theDRC
2018-9 Kivu outbreak, identification of reservoir hosts may assist
in preventing spillover events. Our understanding of pathogenic
filovirus reservoirs is founded on Marburg virus (MARV), a
related filovirus, and its reservoir host the Egyptian rousette bat,
Rousettus aegyptiacus (7). MARVwas directly isolated from cave-
dwelling R. aegyptiacus, which were encountered by humans who
later developed MARV haemorrhagic fever (8). MARV isolates
from this colony successfully reinfect bats upon experimental
infection (7).
Unlike MARV, infectious EBOV has never been isolated from
bats, however numerous human index cases are reported to
have contacted bats prior to developing EVD (9, 10). In the
field, EBOV-specific antibodies and RNA have been detected in
serum and tissue samples from healthy bats, with a predominant
sampling of fruit bats (11, 12). A pioneering study has shown that
not only fruit bats but also the insectivorous bat, M. condylurus
can be experimentally infected with EBOV (13). Not only have
EBOV-specific antibodies been detected in wild populations
of this species but it is also considered as the source of the
2014 outbreak in West Africa as a result of suspected exposure
of an index case to a colony (9). In addition, viral genomic
sequence of Bombali virus, a newly discovered ebolavirus species,
has been detected in swab (14) and tissue samples at high
vRNA levels from wild M. condylurus (15). This collective
information provides conclusive evidence that M. condylurus
plays a considerable role in EBOV ecology.
Studies examining the EBOV infection potential in bats
have focussed on the susceptibility of bat derived fibroblast or
epithelial cell cultures to infection in vitro (16, 17). However,
it is also necessary to study cell types that are key to disease
exacerbation in humans, such as DCs and macrophages as their
aberrant responses to EBOV infection have been implicated
in contributing to EVD (18, 19). Macrophages support EBOV
replication and are thought to contribute to inflammation and
haemorrhagic fever syndrome via excessive cytokine release
and production of reactive oxidative species (20–24). While
DCs also support EBOV replication, they remain in a state of
paralysis depicted by in vitro studies where suppression of surface
expressed maturation markers such as CD80, CD86, and MHC
class II molecules post-infection have been observed paralleled
with the upregulation of T cell inhibitory molecules such as
B7-H1 resulting in PD1 mediated T cell apoptosis (25–27).
In this study, we generated and interrogated the de novo
assembled transcriptome for M. condylurus and identified
immunological reagents to study the susceptibility and immune
response of their BMDCs to EBOV infection. We demonstrated
that bat-BMDCs are susceptible to EBOV infection, which is akin
to findings of past studies that also outline the permissiveness of
human and non-human primate (NHP)monocyte derived DC to
infection. Unlike the antiviral responses of human and NHP DC
to EBOV infection, which are marked by functional impairment
and suppression, we found a feature of the bat-BMDC response
to EBOV was upregulation of the activation-marker CD80
and chemokine CCL3 transcripts, which both correlated with
vRNA amplification. The susceptibility and antiviral responses
of M. condylurus DCs to EBOV infection further support its
status as a reservoir host for Ebolavirus and provide insight into
immunological features of Ebola virus infection in a reservoir
host species.
RESULTS
Assembly and Analysis of M. condylurus
Transcriptome
To identify reagents that could be used to characterize microbat
immune responses to EBOV infection, RNA fromM. condylurus
was sequenced to compile a de novo assembled transcriptome
that contained 547,036 contiguous sequences (contigs)
(Supplementary Table 1). After filtering with Transrate,
the Uniprot database annotated 80,761 contigs confined to
50,691 genes that had various isoforms associated with each
annotation. The median contig length was 888 nucleotides
and the assembly N50 length was 2,345 nucleotides with a GC
content of 46%. Using the Benchmarking Universal Single-Copy
Ortholog (BUSCO) analysis tool we determined 91.1% complete
benchmarking orthologs were detected in the M. condylurus
assembly while 7.2% were fragmented and 1.3% were missing.
In order to compare the sequence similarity of these
identified contigs to sequences within Mammalia in GenBank,
the 80,761 contigs were subjected to a blast2go analysis.
Only BLAST hits with the lowest e-value (top-hits) were
considered in the species analysis to prevent one contig
matching to multiple species. By implementing the query
coverage statistics (qcovs) we calculated 9,316 contigs had
more than 80% of their length aligned to top-hit subject
sequences (Supplementary Table 1). The top-hit counts from
this analysis are shown for species present within the Mammalia
database having more than 1,000 hits detected (Figure 1). To
illustrate relatedness between the species, a phylogenetic tree
for the cytochrome b gene is also depicted vertically in an
iTOL tree diagram. A high number of top-hits matched to
species within the Chiroptera order, including both macrobats
and microbats, albeit contigs blasted more often to the latter,
including Myotis davidii, Myotis brandtii, Myotis lucifugus,
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FIGURE 1 | Mops condylurus transcriptome top-hits to Mammalia in NCBI database. MrBayes phylogenetic tree for the cytochrome B gene was built with Geneious
(v10.0.5) on ClustalW aligned genes. Contigs generated via de novo assembly of M. condylurus sequences were subjected to blast2go analysis against the GenBank
Mammalia database. For each contig a top-hit (blastx match with the lowest e-value) was determined and the number of contigs, for species with more than 1000
top-hits, is represented with horizontal light-blue bars. The order classification for each species is indicated by colored panels. The genome size in megabases and
number of annotated mRNAs present in GenBank, at the time of analysis, are displayed as orange and red heat maps, respectively. This figure was generated with
interactive tree of life (iTOLv1).
and with the highest number of related hits to Miniopterus
natalensis. Interestingly, M. condylurus contigs matched to
a high number of human, Sus scrofa (pig) and Bos mutus
(yak) sequences, despite being phylogenetically distant to
these mammals.
The Identification and Validation of
Cross-Reactive Antibodies to Phenotype
M. condylurus Immune Cells
We sought to identify conserved cell markers expressed by
immune cells by comparing amino acid percent identities
between diverse mammals and M. condylurus, presented as a
heatmap in Figure 2A. Our analyses revealed CD79α, HLA-
DRα, and CD11b of M. condylurus shared >75% identity with
amino acid sequences of other species for which antibodies are
already commercially available (i.e., human, mouse and rat).
The high degree of homology observed was used to select
antibody clones that allow us to distinguish T cells and B
cells based on CD3ε+ and CD79α+ expression, respectively,
in concert with their reciprocal expression of MHC Class II
molecules (HLA-DRα).
Antibody validation was performed using M. condylurus
splenocytes as this lymphoid organ has high lymphocyte and
antigen presenting cell (APC) numbers. Our gating strategy
(Figure 2B) identified a population of cells expressing CD79α
(Figure 2Ci). Expression levels of antigens detected using these
antibodies were well above that when an isotype control was
used (Figure 2D). These cells were also found to express high
levels of MHC Class II (Figure 2E) and are in line with
expected levels of CD79α+MHC Class IIhi B cells in other
species (28). To distinguish CD3ε+ T cells, we also included
an antibody for the activation marker CD44 (Figure 2Cii).
Although no CD44 contig was detected in the M. condylurus
transcriptome, we were able to identify a notable population
of CD3ε+ cells with varying levels of CD44 which may reflect
different activation states (29). These cells were found to express
lower levels of MHC Class II than the CD79α+ population
befitting of CD3ε+MHC Class IIlo−int expression levels, which
can be very diversely regulated on T cells in other species
(Figure 2E) (30).
We verified the use of known DC-associated markers, SIRPα,
CD11b, and MHC Class II (31). For SIRPα, which is less
conserved between M. condylurus and other species examined
(Figure 2A), labeled mRNA probes were designed and utilized
in Prime Flow assays to correlate specific RNA expression
with the binding of a candidate anti-SIRPα antibody. At the
same time a probe designed to detect the housekeeping gene
RPL13 was used to ensure probe hybridization was successful.
Our results show that ∼25% of the total splenocyte population
expressed SIRPα mRNA (Figure 2F). Ninety percent of these
SIRPα mRNA expressing cells were also found to co-express
surface SIRPα as well as CD11b using specific antibodies for
these markers. The high degree of correlation exhibited by the
SIRPα mRNA probe and antibody binding therefore indicates
that bona fide SIRPα is expressed in concert with CD11b+
and represents a viable APC phenotype in M. condylurus.
To examine the frequency of SIRPα+CD11b+ APCs within a
M. condylurus splenocyte population, we gated out T and B cells,
revealing a population of CD79α−CD3ε−SIRPα+CD11b+ cells
(Figure 2Ciii) that exhibited intermediate expression levels of
MHC Class II (Figure 2E).
Using these established antibody panels, we examined the
frequencies of splenic SIRPα+CD11b+ APCs, CD3ε+ T, and
CD79α+ B cells harvested from a larger sample size of bats.
Our results showed T cell frequencies to be greater than APCs
and B cells (Figure 3A). A similar trend was also evident
when cells of each population are expressed as viable cell
number/spleen (Figure 3B). Of note, we found that percentages
of APCs, B cells, T cells to be relatively proportional to each
Frontiers in Immunology | www.frontiersin.org 3 October 2019 | Volume 10 | Article 2414
Edenborough et al. Ebola Virus Infection of Bat-DCs
FIGURE 2 | Phenotyping splenocytes with cross-reactive antibody panels. Protein homology assessment was performed by ClustalW alignment of M. condylurus and
Uniprot sequences belonging to the following species; Myotis brandtii (Microbat), Pteropus alecto (Fruitbat), Equus caballus (Equine), Bos taurus (Bovine), Homo
sapiens (Human), Rattus norvegicus (Rat), and Mus musculus (Mouse). In (A) the alignment is depicted as a heat map for immunological markers that are conserved
across species and used in immune cell phenotyping for this study. *Indicates proteins where only a partial open reading frame was available from the transcriptome
for alignment. Splenocytes were collected from M. condylurus and stained with viable cell dyes (B), cross-reactive antibodies targeting intracellular markers (Cd79α
and Cd3ε) or surface markers (CD44, Cd11b, and SIRPα) (C) and isotype controls (D). An antibody targeting HLA-DRα was used to measure MHC class II expression
on various gated populations (E). PrimeFlowTM probes (F) were designed for less-conserved molecules to correlate antibody binding and mRNA expression.
other within each animal (Figure 3C). For example, animals
with lower percentages of CD79α+ B cells in spleen also
appeared to have lower percentages of CD3ε+ T cells and
SIRPα+CD11b+ APCs.
M. condylurus Phylogeny of GM-CSF and
IL-4
A phylogenetic analysis of IL-4 and GM-CSF sequences
from M. condylurus and mammals for which a number
of immunological reagents are available were undertaken
to determine homologous proteins that could promote
DC differentiation in M. condylurus. ClustalW alignment
of these sequences from M. condylurus with numerous
mammals suggests that murine or human GM-CSF or
IL-4 would not be suitable for DC differentiation due to
the large phylogenetic distances, however, proteins with
greater homology including those from equine or bovine
species would be ideal for propagating bat-BMDC cultures
(Supplementary Figures 2A,B).
Morphology of M. condylurus BMDCs
Generated in vitro in the Presence of
Equine GM-CSF and IL-4
While evaluating the use of recombinant equine IL-4 and
GM-CSF in M. condylurus for bone marrow-derived cultures,
we observed cells with morphological characteristics consistent
with DCs including formation of a stromal cell monolayer
(Figure 4B) and semi-adherent clusters over the course of
6–9 days (Figures 4C,D). This cell differentiation was not
observed in cultures supplemented with murine GM-CSF and
IL-4 (Figure 4A). After 6–10 days punctate veiled spherical
cells possessing motile cytoplasmic projections were also
observed (Figure 4E). While the cultures were heterogenous,
potentially containing macrophages, the predominant cell type
identified displayed distinct motile cytoplasmic projections
(Supplementary Video 1), which is a feature consistent with DC
types rather thanmacrophages (32). DC-like cells from the spleen
could also be propagated using this same method but was found
to yield lower morphologically-similar cell numbers (data not
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FIGURE 3 | Enumerating lymphocyte and DC populations in M. condylurus
spleen. Single cell suspensions were prepared from spleen and stained with
the antibody panels indicated on the x-axis in (A) and the percentage of
Cd79α+, CD3ε+, and SIRPα+CD11b+ cells from 10 individual M. condylurus
bats are shown. Cell number was calculated according to (% of marker positive
population × [% viable cells x (total cell count)]-number of marker positive cells
identified in isotype control stained samples) × total volume spleen (B). An xy
plot correlating CD79α+ cell number with CD3ε+ and SIRPα+CD11b+ cell
numbers is presented (C) with Pearson correlation r values.
shown). Examination of bat-BMDC cultures on day 10 with
scanning electron microscopy revealed predominant round cells
with lamellar and filamentous surface structures (Figure 4F).
Phenotype and Maturation of in vitro
Cultured M. condylurus BMDCs
We next applied the use of the antibody panels to profile bat-
BMDC cultures. By first gating out CD3ε+ T and CD79α+ B
cells, we found that around 30% of remaining cells were CD11b+
and within this population, ∼70% were SIRPα+ (Figure 5A).
Further analysis of these CD3ε−CD79α− SIRPα+CD11b+ cells
revealed ∼40% expressed detectable surface levels of MHC
class II (Figure 5B). These percentages were largely consistent
across cultures derived from different individual bats with the
coefficient of variation observed in each cell population falling
between 13 and 34% (Figure 5C).
In evaluating the functional capacity of these cells to respond
to a TLR agonist, we measured the regulation of surface
expression of MHC Class II following incubation with LPS and
poly IC. Compared to unstimulated cells, of which SIRPα+ live
gated population had a median fluorescence intensity (MFI) of
12,750 for MHC class II expression, cells treated with poly IC
led to increase in levels of MHC class II (Figures 5D,E). Thus,
not only do these propagated cells exhibit a similar APC-like
phenotype as that shown for spleen based on their expression of
SIRPα and CD11b but have an intermediate-high MHC class II
expression level consistent with defined DC phenotypes for other
species and are also activated by typical DC agonists.
EBOV Infection of M. condylurus BMDCs
and Their Chemokine and Cytokine
Responses
To ascertain whether bat-BMDCs are permissive to EBOV
infection in vitro, five separate cultures derived from bat #3, #4,
#42, #43, and #44 were differentiated with IL-4 and GM-CSF
for 6–10 days and then inoculated with EBOV-Zaire to monitor
the development of infection. One culture was inoculated with
GFP-tagged EBOV to visualize the cell types susceptible to
infection, which demonstrated numerous infected cells display
a DC-like morphology (Figures 6A,B), suggesting viral genome
amplification and host responses result from DCs, rather than
from stromal cell infection.
All of the five cultures were inoculated with EBOV for 1 h
and RNAwas extracted from culture supernatants and cell pellets
after 1, 24, 48, and 72 h and EBOV genome copies quantitated by
one-step reverse transcription-qPCR (RT-qPCR). EBOV genome
amplification was detected in culture supernatants and cell pellets
from three bats (#3, #4, and #43) of the five inoculated. In the
cultures from the other two bats (#42 and #44) no increase in
genome amplification over 72 h post infection (HPI) was detected
(data not shown). These cultures did not expand in the presence
of GM-CSF and IL4 and were likely non-viable, hence these
samples were excluded from further analyses.
For the three EBOV-susceptible bat-BMDC cultures, the
vRNA copies detected in supernatant and cell pellets increased
over time as significantly more vRNA copies were detected at
the 24, 48, and 72 h timepoints than 1 HPI (p < 0.01, Tukey’s
multiple comparison test) (Figure 6C). Compared to the number
of vRNA copies detected from cell pellets, more variation was
apparent in supernatant vRNA levels between BMDC cultures
derived from different bats (Figure 6C). Despite this, the levels of
vRNA increased in supernatants within each bat-BMDC culture.
The average fold increase of vRNA detected in supernatants was
1.35 log10 ± 0.298 SD between 1 and 72 HPI.
To determine if enhanced transcription of antiviral-associated
genes in bat-BMDC cultures was induced by EBOV infection,
multiplex one-step RT-qPCR assays were designed to detect
genes previously shown to be upregulated in human DCs and
macrophages during infection with EBOV virus like particles
(VLPs) or during Reston EBOV infection (33). The genes
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FIGURE 4 | Morphology of M. condylurus BMDCs. Dendritic cell morphology of bat bone-marrow cultures is shown on days 5 for cultures supplemented with mouse
GM-CSF/IL4 (A) or equine GM-CSF/IL4 (B) and on days 7 (C) and 9 (D) and 10 (E) for cultures supplemented with equine GM-CSF/IL4. SEM images of DC cultures
were taken on day 10 of culture at 5000x (F) magnification.
encoded for chemokines: CCL20 (MIP3α), CCL11 (eotaxin1),
CCL3 (MIP1α) and activation markers: CCR7, CD80, CD83
and as an extraction control a housekeeping gene was assessed:
RPL13. The efficiency curves and primer sequences for each
target are presented in Supplementary Table 2.
qPCR assays using these primers were performed on RNA
extracted from cell pellets following infection to detect host
specific differences in gene expression in bat-BMDCs. The
expression levels for CCL3, CCL11, CCL20, CCR7, CXCR4, and
CD83 transcripts did not increase significantly in response to
EBOV infection (Figure 6D). CD80 expression was significantly
upregulated at 24 and 48 HPI in comparison to baseline
expression levels at 1 HPI.
The expression levels varied greatly for some transcripts
between individual bats. To develop a more detailed
understanding of transcript expression over time for each
target we correlated fold change with vRNA copies expressed
over the 72 h of infection (Figure 6E). Increase in vRNA copies
for BMDC cultures derived from bats #3, #4, and #43 positively
correlate with increase in expression of two host transcripts;
CD80 and CCL3 (Pearson’s r = 0.020 and 0.049, respectively).
As matched, uninfected BMDC cultures from each individual
bat are used to calculate fold change in gene expression for
each timepoint, the increase in CD80 and CCL3 transcription
coincided only with viral infection.
DISCUSSION
Mops condylurus has been postulated as an Ebola virus reservoir
host due to; its susceptibility to experimental EBOV infection
(13), positive detection of EBOV specific IgG in serum from wild
M. condylurus (34), association with the 2014 outbreak (9) and
the recent detection of a new Ebolavirus species, Bombali virus
in M. condylurus (14) signifying the importance of examining
EBOV infection in this species.
Prior studies investigating the susceptibility of bats to EBOV
infection have focussed on the use of epithelial or fibroblast cell
cultures. These cell types are highly permissive in vitro, and in
vitro susceptibility has not correlated with in vivo susceptibility at
the level of the organism, which has been shown in the case of R.
aegyptiacus (35). Rather than epithelial cells and fibroblasts, DCs
can be used to address impacts of infection on immune induction
such as antigen presentation, T cell activation and stimulation of
inflammatory mediators. Investigating DCs may be specifically
important for EBOV because poor adaptive immune responses
are clearly associated with poor disease outcomes for EBOV
patients (4).
In line with previous findings that mouse CD11b+ DC (36),
monocytes from NHP (37), and cultured DC from human (25)
are susceptible to EBOV infection, in our study we observed
amplification of viral genome in bat-BMDC cultures. Over
the course of infection, genome amplification correlated with
increases in expression of two of the six bat host genes tested
including CD80, a DC activation marker associated with T-cell
priming, and CCL3, a potent chemokine produced by APCs
upon stimulation with LPS. Specifically, for EBOV infection
CCL3/MIP1α gene expression is associated with EBOV-Makona
induced systemic inflammation (37), while CD80 expression is
typically inhibited in DC by EBOV infection, culminating in DC
impairment (22, 38).
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FIGURE 5 | Phenotype and reactivity of M. condylurus BMDCs. BMDC phenotype CD3ε-, CD79α-, Cd11b+ was measured with flow cytometry. BMDC cultures
stained with the markers Cd11b+, SIRPα+, and HLA-DRα+ are portrayed in contour plots (A,B) and the percent of each cell type from cultures of three different wild
caught M. condylurus are shown (C). BMDC cultures at day 6 were treated with or without Poly IC and LPS and the median fluorescence intensity for HLA expression
of SIRPα+ gated cells are shown in (E) for three separate cultures with standard error and representative histograms (D).
Unlike the archetypal dysregulation observed in human
and NHP derived DCs after EBOV infection, our findings
suggest bat-BMDC cultures show features consistent with
DC activation following EBOV infection. As DC activation
is implicated as a key step in immune induction leading
to convalescent outcomes for Ebola infected patients, the
activation of bat-BMDC could be one immunological factor
contributing to the bats inherent ability to develop asymptomatic
infections. To further study the significance of these findings
more extensive immunological tools and phenotyping panels
are required as correlating DC function between species
is complex due to the presence of numerous functionally
distinct subsets that are often not analogous between different
species [reviewed in (39)]. Moreover, the DC surface markers
expressed by one species may not be constitutively expressed
on the surface of another, for example, CD64 has been
used to phenotype human but not mouse macrophages
(40). Other markers such as CD11c (41) and XCR1 (42)
can also be downregulated over time, in culture or during
DC activation.
One limitation of the bat-BMDC culture system described in
our study is that the cultures are heterogeneous, likely containing
macrophages, which would influence experimental outcomes
(32), particularly for the infection studies. The identification
of a macrophage-specific marker that is conserved between
mammals would be particularly helpful to further delineate the
role of macrophages in the infection outcomes we have observed.
The absence of species-specific reagents for M. condylurus was
overcome by use of cross-reactive antibodies and growth factors.
Cross-reactive reagents are typically validated via Western
blotting, however compatibility with flow cytometry applications
was a requirement in this study. Hence, we addressed reagent
validity through multiple steps. Firstly, antibodies that bound
epitopes with high levels of sequence similarity toM. condylurus
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FIGURE 6 | Response of bat-BMDC to EBOV infection. BMDC cultures from bat#4 were infected with GFP-tagged EBOV and cultures were visualized with an EVOS
FL Imaging System at 48 (A) and 72 h post infection (HPI) (B). Day 6–10 BMDC cultures from three separate bats (#3, #4, and #43) were inoculated with EBOV at an
MOI of 3 for 1 h and supernatant and cell pellets were collected at 1, 24, 48, and 72 hpi and subjected to RNA extraction to quantify viral copies. The log10 vRNA
copies/100 µl of supernatant (dark-gray circles) or cell pellet (light-gray squares) are shown for each bat-BMDC culture individually (C). RNA isolated from cell pellet
was further subjected to qPCR assays measuring host transcripts and the relative fold changes in gene expression are shown for CCL3, CCL11, CCL20, CCR7,
CXCR4, CD80, and CD83 in (D), a bar graph showing mean values and standard deviation for the three bat-BMDC cultures tested. Relative fold change was
calculated by (gene absolute copy number in infected cultures/gene absolute copy number in matched and uninfected BMDC cultures) where all values were
normalized to the housekeeping gene RPL13. Significant correlations between viral RNA copies and fold change in host gene expression was determined by
Pearsons test and the linear regression defining the correlations are shown in an xy plot (E). Mixed-effects model with Tukey multiple comparisons posttest
determined significance in (C,D).
were selected. These reagents were further tested in binding
studies with splenocytes, which confirmed if marker co-
expression correlated with established cell phenotypes for other
mammals. Furthermore, we tested relevant markers (MHCII) for
their ability to be upregulated as a result of agonist stimulation.
For markers that had lower levels of sequence homology
to M. condylurus, where antibody binding was observed,
probes were designed to target M. condylurus transcripts to
confirm correlation of RNA and antibody binding. Of interest,
additional markers that we tested on the BMDC cultures did
not yield positive cross-reactivity for antibody binding above
an isotype control in our study despite considerable levels
of amino acid identity to that of a species-relevant amino
acid sequence. This was observed for CADM1 (95% identity),
CD8α (61.9% identity), XCR1 (74.2% identity), and CD4 (total
sequence 55.9% identity, conserved epitope > 95% identity),
suggesting the cellular pattern of expression could be atypical for
these markers.
Studying the response of DCs from different species to EBOV
infection will help pinpoint those likely to act as reservoir
hosts based on the capacity of DC to be activated upon
infection and induce immunity to facilitate viral clearance. This
approach could provide additional information about reservoir
host status to the study of EBOV infection in epithelial cells,
which are less relevant cell type for determining how the
immune system responds to infection. Our findings provide
future impetus to further dissect responses of bat-BMDC to
EBOV infection by evaluating a broader array of genes with
RNAseq or microarrays.
In this study, an M. condylurus transcriptome was compiled
to develop species-specific immunologic tools and we thereby
defined their phylogenetic relationship to other bat species.
Microchiropteran genomes available in GenBank include
those from species within Miniopteridae, Mormoopidae,
Vespertilionidae, Rhinolophidae, and Hipposideridae families
(43). Vespertilionidae shares a distant phylogenetic ancestor to
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Molossidae, the family in whichM. condylurus is classified, going
as far back as the Eocene epoch ∼50 million years ago (44).
Consistent with this, our blast2go analysis of the transcriptome
revealed close evolutionary relationships between M. condylurus
and Miniopterus natalensis, a member of the Vespertilionidae
which also inhabits South-East Africa (45). A high number
of contigs also aligned to other members of Vespertilionidae,
particularly Myotis brandtii, which is distributed in Asia
and Europe, and fewer contigs to Myotis davidii and Myotis
lucifugus, bats which are found in China and the Americas,
respectively. Numerous matches, which did not have a clear
phylogenetic basis included those to Pteropus alecto, which
displayed more sequence matches than other geographically
proximal fruit bats, i.e., Rousettus aegyptiacus. Outside of the
order Chiroptera, top-hit blast matches to human, yak (Bos
mutis) and porcine (Sus scrofa) sequences were identified and are
likely due to well-annotated transcriptomes in GenBank for these
species. However, this is not the case with the high number of
sequence-matches to yak annotations as the number of available
annotations for this species is considerably low. These sequences
were identified as retrotransposon elements.
One limitation of the transcriptome assembled was the sole
use of splenocytes as the source of RNA, which has been shown
to create assemblies enriched in metabolic terms akin to kidney
and lung profiles (46). Expansion to include other tissues such
as lymph node can result in assemblies rich in lymphocyte
and leukocyte activation-associated transcripts (47). While the
inclusion of other tissues such as lymph node would have been
beneficial to the dataset, their collection from healthy microbats
is challenging and in order to generate sufficient RNA for
sequencing, pooling from several bats would be required.
The transcriptomics data was enlisted to elucidate an
appropriate source of growth factors to promote DC
differentiation. The use of non-species-matched growth
factors is a viable approach that has been harnessed for rabbit
(48) and chimpanzee (49) to generate functionally competent
DCs that can be matured by TLR ligands, phagocytose FITC
dextran and also induce T cell proliferation in mixed leukocyte
reaction assays. Our phylogenetic results suggested that bovine
or equine growth factors are suitable for M. condylurus BMDC
propagation. We focussed on equine GM-CSF/IL4, as it has
been previously indicated as an ideal supplement to propagate
fruit bat BMDCs (50). An advantage of using recombinant
supplements rather than a cell-culture derived species-matched
method in the form of supernatants (51), is the availability of
specific growth factors at well-defined concentrations allowing
for accurate dosing as well as dose-optimisation.
The transcriptomics-driven approach we have described here
to identify and validate cross-reactive markers and reagents
provides an ideal platform that can be utilized to provide further
insight into not only how M. condylurus but also other bat
species can behave as reservoir hosts. Overall, our research
highlights that bat-BMDCs are activated as part of the reservoir
host response to EBOV infection, which provides evidence and
rationale for the development and use of targeted approaches to
activate and overcome DC-dysfunction in humans to improve
protection against EBOV-disease.
METHODS
Bat Tissue and Bone Marrow Collection
Animal work and necropsies were performedwith the permission
of the Laboratoire Central Vétérinair, Laboratoire National
d’Appui au Développement Agricole (LANADA), Bingerville,
Ivory Coast (No. 05/virology/2016). The animal care and use
protocol adhered with the ethics committee of LANADA and
National Ethics Committee for Research (CNER). Consent
existed to capture the bats from the owners of the residence
in Koffikro Village After 2–4 weeks of housing, the bats
were anesthetized with Isoflurane (1,214, cp-pharma R©) and
euthanized by decapitation.
Humeri, femurs and sternum were removed from male
bats (weighing between 26 and 35 g each). Muscle and
fascia were extirpated with a scalpel and the bones rinsed
with 70% ethanol. Bones were transversally sectioned with
scissors and the bone marrow was flushed from the bone
with Recovery TM Cell Culture Freezing Medium (12648010,
Gibco) using a cannula (Braun Sterican R© Gr. 18) and
collected cells cryopreserved at −80◦C. The spleen was
removed and single cell suspensions were produced by
slicing it into smaller pieces, which were added to cRPMI
medium, comprising RPMI-1640 (Sigma, R8758) containing
10% (v/v) FBS, 10 U/ml Penicillin and 10µg/ml Streptomycin
(15140122, ThermoFisher), 40µM β-Mercaptoethanol (4227.3,
Roth), 10mM HEPES (15630106, ThermoFisher), and 25 U/ml
Benzonase (71205-3, Milipore) and gently sieved through a
100µM strainer (352360, Falcon). Following centrifugation, cells
were treated with ACK lysis buffer (A1049201, ThermoFisher) for
6min at room temperature, washed in cRPMI and resuspended
in freezing media, cryopreserved and transported to the RKI in a
cryogenic dry shipper.
Stimulation of Splenocytes
Splenocytes were rested in complete IMDM (cIMDM)
(Sigma) containing 10% FBS, 10 U/ml Penicillin and 10µg/ml
Streptomycin, 40µM β-Mercaptoethanol and 10mM HEPES.
Following centrifugation, splenocytes were re-suspended
and 8.5–10 × 105 cells were seeded in 96-well flat-bottom
plates. Following overnight culture at 37◦C, splenocytes
were stimulated with an agonist array; either 10 µg/200 µl
lipopolysaccharide (LPS) from Escherichia Coli 011:B4 (tlrl-
eblps, Invivogen), 10 µg/200 µl Concanavalin A (ConA)
(C0412, Sigma), 1 µg/200 µl Phorbol myristaste acetate (PMA)
(tlrl-pma, Invivogen) mixed with 10 µg/200 µl Ionomycin
(inh-ion, Invivogen) or transfected with 1 µg/200 µl high
molecular weight polyinosinic:polycytidylic acid (poly I:C)
(tlrl-pic, Invivogen) using 3 µl Lipofectamine 3000 (L3000001,
LifeTechnologies). After 6 h, RNA was extracted with use
of TRIzol Reagent (10296028, Invitrogen) according to
manufacturer’s instructions. The RNA pellet was visualized by
the addition of 1 µl of glycogen (10901393001, Roche) and
re-suspended in 40 µl RNase free water. RNA yields ranged from
20 to 25 ng/µl as measured with high sensitivity Qubit kits
(Q32852, ThermoFisher).
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Rapid Amplification of cDNA Ends (RACE)
5′ and 3′ RACE was performed according to previously
published methods with RNA harvested from M. condylurus
splenocytes (52).
Transcriptome Sequencing and Analysis
Transcriptomics was performed with splenocytes treated with
an agonist array to enrich for transcripts associated with an
immune response. To determine the optimal for measuring
immune associated transcripts, M. condylurus splenocytes
were first stimulated with poly IC and IFN-β transcripts
detected with endpoint PCR. The mRNA sequence for IFN-
β was determined by RACE to design specific primers
(Supplementary Figure 1A). We found that relative to a
housekeeping gene, cytochrome b, which was detectable at all
times examined, IFN-β PCR products were first visualized at 6 h
post stimulation (Supplementary Figure 1B).
In a separate experiment splenocytes were treated with the
agonist array and RNA for transcriptomic analysis was collected
after 6 h. With the aim of generating as many annotations
as possible, RNA harvested following all treatments were
pooled and analyzed. The transcriptome was sequenced with
Illumina HiSeq (Illumina) on rapid run mode as a 250 bp
paired end library. One limitation of the data analysis was
that the read pairs overlapped in >90% of the sequenced
fragments, due to a majority of short DNA fragments in the
sequencing library. Hence only the forward reads were used
for transcriptome assembly as the reverse reads did not yield
additional information.
Quality control and read trimming was performed with
QCumber2 (https://gitlab.com/RKIBioinformaticsPipelines/QC
umber) filtering out bases with Phred scaled quality of
<30 and reads with a minimum sequence length of 50
nt. Trimmed reads are publicly available at NCBI accessible
with biosample number SAMN10439459 and project number
PRJNA506280. De novo assembly quality and annotation were
performed of the Oyster River Protocol, which used the
Trinity Platform to assemble and annotate transcriptomes
from RNAseq data (53). Retained reads from QCumber2
(122,907,600) were subjected to de-novo assembly with Trinity
(v2.4.0) and Transrate (v1.0.3) was applied to filter out
poorly covered contiguous sequences (contigs). Approximately
80,000 contigs were able to be annotated by Uniprot with
Trinotate (v3.0.2) and Transdecoder (v4.1.0). Further analysis
of trinity annotated contigs was performed with blast2go
workbench (54). The amino acid sequences of immune proteins
were aligned with use of ClustalW (55) or MUSCLE in
Geneious (v10.0.5).
Bone Marrow DC Cultures
Thawed bone marrow cells (∼1 × 106) were cultured in
3ml cIMDM containing 20 ng/ml equine IL-4 (REIL4I, Fisher
Scientific) and GM-CSF (ICT-6379, Biomol) at 37◦C and 5%CO2
in a 35mm bacterial petri dish (430588, Corning). On days 2, 4, 7
and 9, cells were fed with fresh medium containing IL-4 and GM-
CSF by gently removing 2ml of supernatant without disturbing
the cell monolayer, pelleting the cells at 300 g for 5min and
resuspension of the centrifuged pellet in 2ml of fresh cytokine
supplemented cIMDM. Non-adherent cells from bone marrow
cultures were used between day 6 and 10 for phenotypic and
functional assays.
Scanning Electron Microscopy (SEM)
BMDC were flushed from 35mm petri dishes and allowed to
absorb for 3 h on round glass 13mm coverslips in TC 24-well
plates. Coverslips with adherent cells were fixed in buffered
(0.05M HEPES, pH 7.2) 2.5% glutaraldehyde, for 2 h at room
temperature and then, gently washed with distilled water prior
to post-fixation in 1% OsO4 (1 h). After a further wash in
distilled water, samples were dehydrated in an ethanol series
(30, 50, 70, 90, and 96% for 15min each and absolute ethanol
for 30min) and critical point dried (CPD 300, Leica, Germany)
using carbon dioxide. Finally, the samples were coated with 2 nm
gold/palladium using a sputter coater (E5100 Polaron/Quorum
Technologies, UK,) and examined in a field emission scanning
electron microscope (Leo 1530 Gemini, Carl Zeiss Microscopy,
Germany) at 3 kV acceleration voltage and a working distance
of 4.2mm. Signals from an in-lens-SE and an Everhart-Thornley
secondary electron detector were mixed (50:50%) for the imaging
of all samples.
Flow Cytometric Staining of Splenocytes
and DCs
Splenocytes were thawed and re-suspended in 8ml of cIMDM
prior to staining with antibodies whilst BMDCs were harvested
directly from cell cultures. Following one wash in phosphate
buffered saline (PBS), cells were stained with BV405 vitality dye
(L34964, ThermoFisher) at a 1:100 dilution in PBS for 10min
at room temperature. Following two consecutive washes in
PBS containing 10% FBS, cells were resuspended in 0.1ml 10%
normal goat serum. Extracellular staining with the following
antibodies in staining buffer (FBØ), which contained 1mM
EDTA, 1% bovine serum albumin (BSA) and 0.1% sodium
azide (NaN3), was performed prior to fixation; α-bovine-
SIRPα (clone DH59B, KingFisher Biotech) diluted 1:50 and
detected with a secondary goat α-mouse IgG-PEC7 (clone
Poly4053, BioLegend) diluted 1:200, α-mouse-CD11b-PE
(clone M1/70, BD Pharmingen) diluted 1:100, α-human-
CD44-APC-eFluor R©780 (clone IM7, eBioScience) diluted
1:50 and α-human-HLA-DR-BV785 (Clone L243, BioLegend)
diluted 1:50. Following fixation with 4% paraformaldehyde
for 30min at 4◦C, cells were permeabilised with 0.1% saponin
for 20min at room temperature. Intracellular staining was
then performed with the following antibodies; α-mouse-CD3ε
(clone 145-2C11, BioLegend) diluted 1:50 and α-mammal-
CD79α-APC (clone HM57, Abnova) diluted 1:20. Following
30min of incubation, cells were washed twice in FBØ and
samples were subjected to flow cytometric analysis (CytoFLEX
cytometer, Beckman Coulter) and analyzed with CytExpert and
Cytobank software.
Prime-Flow Probes and Staining
Splenocytes 106 per sample were incubated at 37◦C for 30min
and then stained with BV405 vitality dye and the surface
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markers SIRPα and CD11b as per flow cytometry assays.
PrimeFlow staining was carried out as per manufacturer
instructions (PrimeFlowTM RNAAssay, eBioscience) with the test
probes; Type4-RPL13 and Type1-SIRPα. RPL13 was used as a
positive control.
DC Infection and Measurement of Viral
RNA Copy Number
BMDCs were utilized for infection studies between days 6
and 10 of culture. Cultures from each bat were infected with
EBOV-Makona at a MOI of 3 for 1 h, thereafter BMDCs were
washed with fresh media and were seeded into 48-well plates
at a concentration of 2.5 × 105 cells/well. Mock uninfected
control samples were also set up as a negative control. Cells
were harvested at 1, 24, 48, and 72 h post-infection (hpi) and
resuspended in RLT Buffer (Qiagen). Supernatants from cultures
were also collected into AVL Buffer (Qiagen). RNA was extracted
according to the manufacturer’s instructions using RNeasy, for
cell pellets, and Qiamp Kits, for cell supernatants (Qiagen).
EBOV transcripts were quantified using a quantitative PCR
(qPCR) assay targeting EBOV-VP30 with use of AgPath-ID One
Step RT-PCR Kit (4387391, ThermoFisher). Reactions of 25
µl were formulated by addition of 3 µl of RNA sample to a
master mix containing: 400 nm of forward and reverse primer,
200 nm of TaqMan Probe, 1 µl enhancer, 1X buffer, and 1X
RT-PCR enzyme mix. The thermal profile included incubation
at 15min 45◦C, 10min 95◦C, and 45 cycles of 15 s 95◦C
and 45 s 60◦C. The sample CTs were compared to a standard
curve, which was produced using EBOV in vitro transcripts
of known concentrations that ranged from 101 to 107 copies.
This standard curve was used to quantify copy numbers within
each sample.
Development of M. condylurus-Specific
qPCR Assays
Plasmids encoding M. condylurus genes downstream of a T7
promoter were synthesized (Aldevron, USA) for the purposes of
in vitro RNA synthesis. PCR products were produced by M13
primed standard PCR (PlatinumTaq, ThermoFisher) to yield 50–
500 ng/µl of template which was added to HiScribeTM T7 High
Yield RNA Synthesis reactions (E2040S, NEB) for transcription
carried out overnight at 37◦C. Reaction constituents were added
according to manufacturer’s instructions. In vitro transcribed
RNA was DNase treated for 30min (Ambion) and purified with
4M LiCl and two 70% ethanol washes. RNA size was confirmed
on a bleach gel containing 0.6% sodium hypochlorite. qPCR
primer and probe sequences are listed (Supplementary Table 2)
and were designed with Geneious workbench 10.0.5. Primers
were further filtered to reduce dimer and heterodimer formation
likelihood with use of IDT Oligo Analyzer 3.1. Primer and
probe concentrations were optimized for use with LunaUniversal
Probe qPCR mix (M3004, NEB) to produce an efficiency of
>90% within a multiplex configuration. The housekeeping gene
RPL13 was included in each multiplex panel as a reference
for each assay. Each assay included positive RNA controls
to generate a standard curve that was fitted using a non-
linear regression analysis (GraphPad Prism, USA). This was
then used to determine the slope and y-intercept, which
was transformed to calculate copy number/ng in the original
RNA sample.
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